by Dr Carmine R. Grieco III, CSCS,*D
Personal Training Quarterly
June 2021
Vol 8, Issue 1
Paywall block issue
This article is not configured properly for members or paid content.
isMemberOnly: {{isMemberOnly}} | isPaidContent: {{isPaidContent}}
spc: One or more parts of the product SPC is missing.
Read the full article
View the video
Login to view more
This {{ogType == 'video.other' ? 'video':'article'}} is available with a NSCA membership
or can be purchased for {{prices}}
or can be purchased. Price range: {{prices}}
Price includes membership pricing and promotions
This {{ogType == 'video.other' ? 'video':'article'}} can be purchased for {{prices}}
Price includes membership pricing and promotions
Purchase this {{ogType == 'video.other' ? 'video':'article'}}. Price range: {{prices}}
Price range includes membership pricing and promotions
This article originally appeared in Personal Training Quarterly (PTQ)—a quarterly publication for NSCA Members designed specifically for the personal trainer. Discover easy-to-read, research-based articles that take your training knowledge further with Nutrition, Programming, and Personal Business Development columns in each quarterly, electronic issue. Read more articles from PTQ »
1. Andersen, LPH, Gögenur I, Rosenberg, J and Reiter, RJ. The safety of melatonin in humans. Clinical Drug Investigation 36(3): 169-175, 2016.
2. Auld, F, Maschauer, EL, Morrison, I, Skene, DJ and Riha, RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews 34: 10-22, 2017.
3. Besag, FMC, Vasey, MJ, Lao, KSJ and Wong, ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: A systematic review. CNS Drugs 33(12): 1167-1186, 2019.
4. Brzezinski, A, Vangel, MG, Wurtman, RJ, Norrie, G, Zhdanova, I, Ben-Shushan, A, and Ford, I. Effects of exogenous melatonin on sleep: A meta-analysis. Sleep Medicine Reviews 9(1): 41-50, 2005.
5. Centers for Disease Control and Prevention. Short sleep duration among US adults. Retrieved December 11, 2020 from https://www.cdc.gov/sleep/data_statistics.html.
6. Chong, Y, Fryer, CD, and Gu, Q. Prescription sleep aid use among adults: United States, 2005-2010. NCHS Data Brief 127: 1-8, 2013.
7. Clarke, TC, Black, LI, Stussman, BJ, Barnes, PM, and Nahin, RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. National Health Statistics Reports 10(79): 1-16, 2015.
8. Claustrat, B, and Leston, J. Melatonin: Physiological effects in humans. Neuro-Chirurgie 61(2-3): 2015.
9. Costello, RB, Lentino, CV, Boyd, CC, O’Connell, ML, Crawford, CC, Sprengel, ML, and Deuster, PA. The effectiveness of melatonin for promoting healthy sleep: A rapid evidence assessment of the literature. Nutrition Journal 13: 2014.
10. Erland, LAE, and Saxena, PK. Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine 13(2): 275-281, 2017.
11. Ferracioli-Oda, E, Qawasmi, A, and Bloch, MH. Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLoS One 8(5): 2013.
12. Foley, HM, and Steel, AE. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complementary Therapies in Medicine 42: 65-81, 2019.
13. Gonciarz, M, Mularczyk, A, Szkudłapski, D, Konturek, SJ, and Konturek, PC. A case of melatonin-induced biochemical flare in a patient with primary sclerosing cholangitis with features of autoimmune hepatitis. Przeglad Gastroenterologiczny 14(2): 157-159, 2019.
14. Grigg-Damberger, MM, and Ianakieva, D. Poor quality control of over-the-counter melatonin: What they say is often not what you get. Journal of Clinical Sleep Medicine 13(2): 275-281, 2017.
15. Härtter, S, Nordmark, A, Rose, DM, Bertilsson, L, Tybring, G, and Laine, K. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. British Journal of Clinical Pharmacology 56(6): 679-682, 2003.
16. Herxheimer, A, and Petrie, KJ. Melatonin for the prevention and treatment of jet lag. The Cochrane Database of Systematic Review 2: 2002.
17. Hilli, J, Korhonen, T, Turpeinen, M, Hokannen, J, Mattila, S, and Laine, K. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2g. -163C>A polymorphism. Journal of Clinical Pharmacology 48(8): 986-984, 2008.
18. Hong, YG, and Riegler, JL. Is melatonin associated the development of autoimmune hepatitis? Journal of Clinical Gastroenterology 25(1): 376-378, 1997.
19. Li, T, Jiang, S, Han, M, Yang, Z, Lv, J, Deng, et al. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Frontiers in Neuroendocrinology 52: 22-28, 2018.
20. Liira, J, Verbeek, JH, Costa, G, Driscoll, TR, Sallinen, M, Isotalo, LK, and Ruotsalainen, JH. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. The Cochrane Database of Systematic Reviews 8: 2014.
21. Mordor Intelligence. Melatonin market – Growth, trends, and forecast (2020 – 2025). Retrieved December 2, 2020 from https://www.mordorintelligence.com/industry-reports/ melatonin-market.
22. Nawaz, MA, Huang, Y, Bie, Z, Ahmed, W, Reiter, RJ, Niu, M, and Hameed, S. Melatonin: Current status and future perspectives in plant science. Frontiers in Plant Science 11: 2016.
23. Newmaster, SG, Grguric, M, Shanmughanandhan, D, Ramalingam, S, and Ragupathy, S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Medicine 11: 2013.
24. Pierce, M, Linnebur, SA, Pearson, SM, and Fixen, DR. Optimal melatonin dose in older adults: A clinical review of the literature. The Senior Care Pharmacist 34(7): 419-431, 2019.
25. Reiter, RJ. The pineal gland and melatonin in relation to aging: A summary of the theories and of the data. Experimental Gerontology 30(3-4): 1995.
26. Reiter, RJ, Mayo, JC, Tan, DX, Sainz, RM, Alatorre-Jimenez, M, and Qin, L. Melatonin as an antioxidant: Under promises but over delivers. Journal of Pineal Research 61(3): 253-278, 2016.
27. Sateia, MJ, Buysse, DJ, Krystal, AD, Neubauer, DN and Heald, JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine 13(2): 2017.
28. Tournas, VH. Microbial contamination of select dietary supplements. Journal of Food Safety 29: 430-442, 2009.
29. Ursing, C, von Bahr, C, Brismar, K, and Röjdmark, S. Influence of cigarette smoking on melatonin levels in man. European Journal of Clinical Pharmacology 61(3): 197-201, 2005.
30. Vural, EMS, van Munster, BC, and de Rooij, SE. Optimal dosages for melatonin supplementation therapy in older adults: A systematic review of current literature. Drugs and Aging 31(6): 441-451, 2014.
31. Xie, Z, Chen, F, Li, WA, Geng, X, Li, C, Meng, X, et al. A review of sleep disorders and melatonin. Neurological Research 39(6): 559-565, 2017.
32. Zhang, Q, Gao, F, Zhang, S, Sun, W, and Li, Z. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in intensive care units: A systematic review and meta-analysis of randomized controlled trials. Sleep and Breathing 23(4): 1059-1070, 2019.
33. Zhang, R, Wang, X, Ni, L, Di, X, Ma, B, Niu, S, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences 250, 2020.